
Sign up to save your podcasts
Or


Plus: American Express shares fell after its outlook for the year disappointed investors. Verizon stock rose after beating Wall Street expectations. And Novo Nordisk surged after positive results from a clinical trial of an experimental weight loss drug. Danny Lewis reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The Wall Street Journal4.2
651651 ratings
Plus: American Express shares fell after its outlook for the year disappointed investors. Verizon stock rose after beating Wall Street expectations. And Novo Nordisk surged after positive results from a clinical trial of an experimental weight loss drug. Danny Lewis reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2,863 Listeners

1,721 Listeners

966 Listeners

4,383 Listeners

402 Listeners

434 Listeners

1,663 Listeners

1,449 Listeners

1,052 Listeners

1,305 Listeners

6,092 Listeners

1,576 Listeners

211 Listeners

1,324 Listeners

588 Listeners

151 Listeners

88 Listeners

75 Listeners

142 Listeners